Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-09 Sale | 2024-01-11 5:04 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,812 | $16.33 | $45,915 | 205,605 (Direct) | View |
| 2023-05-15 Sale | 2023-05-17 4:58 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 11,965 | $29.03 | $347,358 | 257,591 (Direct) | View |
| 2023-04-17 Sale | 2023-04-19 7:45 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 49,579 | $30.54 | $1,513,942 | 269,556 (Direct) | View |
| 2023-03-16 Sale(A) | 2023-03-24 6:45 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 54,627 | $31.87 | $1,741,200 | 360,385 (Direct) | View |
| 2023-03-16 Sale | 2023-03-20 8:25 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 54,627 | $31.87 | $1,741,200 | 200,089 (Direct) | View |
| 2023-01-06 Sale | 2023-01-10 7:22 pm | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,034 | $36.3 | $73,831 | 204,299 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A 2029-03-18 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 11,965 | $0 | 257,591 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,201 | $0.37 | 257,591 (Direct) | View |
| 2023-05-15 Exercise | 2023-05-17 4:58 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 9,764 | $6.88 | 257,591 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 7:45 pm | N/A 2029-03-18 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 49,579 | $0 | 269,556 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 7:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 44,861 | $0.37 | 269,556 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 7:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 4,718 | $6.88 | 269,556 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 2,789 | $0.33 | 360,385 (Direct) | View |
| 2023-03-16 Option Award(A) | 2023-03-24 6:45 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 50,417 | $0 | 360,385 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:45 pm | N/A 2028-02-16 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 49,578 | $0 | 360,385 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 30,041 | $0.37 | 360,385 (Direct) | View |
| 2023-03-16 Exercise(A) | 2023-03-24 6:45 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 16,748 | $6.88 | 360,385 (Direct) | View |
| 2023-03-16 Option Award | 2023-03-20 8:25 pm | N/A 2033-03-16 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 50,417 | $0 | 200,089 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 8:34 pm | N/A 2032-01-06 | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 155,833 | $0 | 333,833 (Direct) | View |
Ownership | 2022-01-06 5:02 pm | N/A N/A | Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer | 0 | $0 | 338,296 (Direct) | View |